查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945110

油溶性金奈米棒市場按材料類型、表面功能化、應用和終端用戶產業分類－全球預測，2026-2032年

Oil-soluble Gold Nanorods Market by Material Type, Surface Functionalization, Application, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，油溶性金奈米棒市場價值將達到 4,593 萬美元，到 2026 年將成長至 5,288 萬美元，到 2032 年將達到 7,237 萬美元，複合年成長率為 6.71%。

關鍵市場統計數據
基準年 2025 4593萬美元
預計年份：2026年 5288萬美元
預測年份 2032 7237萬美元
複合年成長率 (%) 6.71%

對油溶性金奈米棒的科學基礎和商業化挑戰進行策略性介紹：確定轉化研究和開發的優先事項

油溶性金奈米棒代表了奈米工程與應用導向型轉化科學的交叉領域，其獨特的光學、熱學和表面化學性質日益受到研究人員和產品開發人員的青睞。它們異向性的形狀和可調諧的等離子體共振使其能夠在成像和光熱治療相關的波長範圍內與光和熱進行精確相互作用，而其油溶性則為在疏水性基質和脂質遞送系統中進行製劑開發開闢了新的可能性。

合成技術、表面化學、監管法規的進步以及數位化可追溯性的提升，正在改變油溶性金奈米棒的開發和應用路徑。

多種技術和監管變革的融合正在重塑油溶性金奈米棒領域的格局，這些變革加速了轉化應用進程，同時也提高了可重複性和安全性方面的要求。合成控制技術的進步使得更精細的長寬比分佈和窄頻的光學特性成為可能，從而可靠地整合到診斷儀器和光學成像工作流程中。同時，表面塗層技術和功能化化學的創新正在促進金奈米棒在非極性介質中的穩定分散以及對生物分子的選擇性結合。

評估美國關稅政策對油溶性金奈米棒開發公司採購選擇、製造地決策和合作研究趨勢的影響

美國和全球貿易政策趨勢影響先進材料（包括油溶性金奈米棒）的採購、製造地和夥伴關係策略決策。關稅提高了關鍵原料和成品的到岸成本，促使製造商和創新者重新思考其價值鏈活動的開展地點和方式。實際上，這種動態正在推動供應商多元化，將採購轉向盟國，並在條件允許的情況下增加國內契約製造的使用。

多維細分分析揭示了應用、最終用途、材料類型和表面功能化如何決定開發和商業化優先事項。

全面的市場區隔分析揭示了技術和商業性優先事項的交會點，以及不同應用情境和材料特性所導致的開發路徑差異。按應用場景分類，本報告考察了診斷、藥物傳輸、成像和光熱治療市場，並在診斷領域進一步分析了生物感測和癌症診斷。這種細分突顯了不同的檢驗要求：生物感測應用優先考慮表面化學穩定性和最佳化的信噪比，而癌症診斷則要求嚴格的特異性和臨床檢驗途徑。

戰略區域分析：管理體制、製造能力和轉化生態系統對美洲、歐洲、中東和非洲以及亞太地區應用的影響

區域特徵影響人才、資本、法規結構和製造基礎設施的獲取，了解這些差異對於制定可行的打入市場策略至關重要。美洲地區集中了眾多轉化研究中心、臨床試驗基礎設施和合約開發組織，這些機構推動臨床研發管線的發展。這種環境使得從實驗室發現到臨床檢驗的迭代過程得以快速推進，但也對研發人員提出了嚴格的監管和品質要求。

競爭格局評估重點闡述了合成規模化生產能力、專有塗層技術和策略夥伴關係關係如何在特殊材料領域創造商業性優勢。

油溶性金奈米棒的競爭格局由專業材料開發商、成熟的奈米材料供應商以及連接研發和生產的合約組織共同構成。該領域的領導企業憑藉其在合成規模化方面的深厚專業知識、增強在非極性基質中分散性的專有塗層化學技術以及可實現靶向診斷和治療應用的檢驗表面功能化工藝脫穎而出。夥伴關係與授權協議十分普遍，這使得學術研究人員能夠獲得商業級生產能力和監管方面的專業知識，同時也使企業能夠在無需承擔全部研發風險的情況下拓展其應用組合。

為經營團隊提供切實可行的、優先考慮的建議，以穩定供應鏈、提高分析嚴謹性並加速油溶性金奈米棒技術的實用化。

產業領導者應優先採取切實可行的措施，在短期風險緩解與釋放長期商業性價值的投資之間取得平衡。首先，應加強關鍵前驅物和塗層材料的供應商多元化，以降低關稅造成的成本波動和供應中斷風險。此外，還應建立正式的備選供應商資格認證通訊協定，並維護經過審核的供應商優先名單，以最大限度地減少研發專案的延誤。

結合專家訪談、技術檢驗和三角驗證證據的透明混合調查方法，為油溶性金奈米棒的研究提供了可操作的見解。

這些研究結果所依據的研究方法結合了系統性的文獻綜述、有針對性的專家訪談，以及對公開文件和公司揭露資訊中技術和監管訊號的交叉檢驗。關鍵的定性研究內容包括對材料科學家、配方化學家、法規顧問以及在等離子體奈米材料或轉化開發流程方面具有直接經驗的合約開發組織（CDO）代表的訪談。

本文簡要概述了技術、監管和策略的考量因素，這些因素共同構成了油溶性金奈米棒創新技術商業化的切實可行的路徑。

油溶性金奈米棒兼具先進材料特性和多樣化應用前景，佔據著極具吸引力的市場地位。然而，要充分發揮其潛力，必須嚴格關注可重複性、法規遵循、策略性供應鏈設計。儘管合成精度、塗層化學和功能化方面的技術進步拓展了其應用範圍，但不斷變化的監管要求和貿易政策既構成了限制因素，也獎勵著研發人員思考如何建立夥伴關係和製造地。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依材料類型分類的油溶性金奈米棒市場

  • 塗層
    • 聚乙二醇塗層
    • 聚合物塗層
    • 二氧化矽塗層
  • 未塗層

9. 依表面功能化分類的油溶性金奈米棒市場

  • 功能化
    • 抗體功能化
    • DNA功能化
  • 不具備功能

第10章 依應用分類的油溶性金奈米棒市場

  • 診斷
    • 生物感
    • 癌症診斷
  • 藥物輸送
  • 影像
  • 光熱治療

第11章 依終端應用產業分類的油溶性金奈米棒市場

  • 化妝品
  • 衛生保健
  • 研究所

第12章 油溶性金奈米棒市場（依地區分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 油溶性金奈米棒市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國油溶性金奈米棒市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 美國油溶性金奈米棒市場

第16章 中國油溶性金奈米棒市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • American Elements
  • BBI Solutions by Novo Holdings A/S
  • CD Bioparticles
  • Cytodiagnostics Inc.
  • Emfutur Technologies
  • Innova Biosciences
  • Meliorum Technologies, Inc.
  • nanoComposix by Fortis Life Sciences
  • Nanocs, Inc.
  • Nanopartz Inc.
  • Nanoprobes, Inc.
  • Plasmachem GmbH
  • RuixiBiotechCo.Ltd
  • Sigma-Aldrich Corporation
  • TANAKA Holdings Co., Ltd.
Product Code: MRR-8D2A80511E89

The Oil-soluble Gold Nanorods Market was valued at USD 45.93 million in 2025 and is projected to grow to USD 52.88 million in 2026, with a CAGR of 6.71%, reaching USD 72.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 45.93 million
Estimated Year [2026] USD 52.88 million
Forecast Year [2032] USD 72.37 million
CAGR (%) 6.71%

A strategic introduction to the scientific fundamentals and commercialization challenges of oil-soluble gold nanorods that frame translational and development priorities

Oil-soluble gold nanorods represent a convergence of nanoscale engineering and application-driven translational science, offering unique optical, thermal, and surface chemistry attributes that are increasingly attractive to researchers and product developers. Their anisotropic shape and tunable plasmonic resonance enable precise interaction with light and heat at wavelengths relevant to imaging and photothermal modalities, while oil solubility expands formulation possibilities for hydrophobic matrices and lipid-based delivery systems.

Transitioning these materials from research laboratories into regulated applications requires coordinated advances across synthesis reproducibility, surface chemistry control, and scalable coating technologies. Manufacturing reproducibility is critical because subtle variations in aspect ratio, surface ligands, or coating integrity can materially alter biological interaction profiles. At the same time, formulation scientists are exploring how oil-compatible carriers can preserve optical performance while improving biodistribution and interface with existing drug delivery platforms.

Stakeholders should therefore view oil-soluble gold nanorods as both a platform technology and a materials challenge. The platform dimension offers multiple pathways for differentiation in diagnostics, imaging, and targeted therapy contexts, whereas the materials challenge demands systematic attention to interfacial chemistry, solvent compatibility, and analytical methods that verify batch-to-batch consistency. This balanced perspective frames the subsequent analysis of technological shifts, regulatory influences, segmentation dynamics, and regional strategic considerations.

How advances in synthesis, surface chemistry, regulatory rigor, and digital traceability are transforming development and adoption pathways for oil-soluble gold nanorods

The landscape for oil-soluble gold nanorods is being reshaped by several convergent technological and regulatory shifts that are accelerating translational pathways while also raising the bar for reproducibility and safety. Advances in synthetic control now permit tighter aspect ratio distributions and narrower optical signatures, enabling more reliable integration into diagnostic instruments and optical imaging workflows. Alongside these advances, innovations in surface coatings and functionalization chemistries are allowing more stable dispersion in nonpolar media and more selective biomolecular conjugation.

Regulatory expectations are evolving in parallel: agencies are increasingly focused on detailed characterization of nanomaterials, including impurity profiles, coating stability, and the behavior of functionalized surfaces in biological environments. This is prompting developers to improve analytical rigor and to adopt standardized assays that can withstand regulatory scrutiny. In the commercial domain, cross-sector collaboration is becoming a key enabler; diagnostic companies, contract manufacturers, and academic translational centers are forming partnerships to bridge gaps between proof-of-concept studies and clinical-grade production.

At the same time, digital tools for characterization and supply chain traceability are growing in importance. High-resolution imaging, single-particle analytics, and blockchain-enabled provenance tracking are emerging as complementary technologies that increase confidence in quality and origin, which is particularly important for sectors with stringent safety profiles. These transformative shifts are creating a dual imperative: accelerate innovation while investing in robust controls that enable regulatory acceptance and market adoption.

Assessing how US tariff policies influence sourcing, manufacturing location decisions, and collaborative research dynamics for oil-soluble gold nanorod developers

Trade policy developments in the United States and globally influence decisions across sourcing, manufacturing footprint, and partnership strategies for advanced materials such as oil-soluble gold nanorods. Tariff measures can raise the landed cost of key inputs and finished components, prompting manufacturers and innovators to reassess where and how value chain activities are performed. In practice, this dynamic encourages a diversification of suppliers, a shift in procurement toward allied jurisdictions, and increased utilization of domestic contract manufacturing where feasible.

Beyond direct cost implications, tariffs affect the broader ecosystem by altering collaboration incentives. Academic-industry partnerships and cross-border research consortia may face new administrative overhead when material transfers become subject to additional duties or certifications, which can slow iterative experimental cycles. Regulatory harmonization efforts and free trade agreements can mitigate some friction, but uncertainty around policy persistence increases the value of flexible sourcing strategies and dual-sourcing arrangements.

For developers, an effective response to tariff-driven disruption is to combine near-term operational adjustments with medium-term strategic realignment. Near-term tactics include optimizing bill-of-materials visibility, qualifying alternative suppliers for precursors and coatings, and revisiting contractual terms to allocate tariff risk. Over the medium term, investing in regional manufacturing capabilities, forming strategic alliances with local contract manufacturers, and leveraging regulatory compliance as a differentiation point can reduce exposure and preserve time-to-market. These actions maintain continuity in R&D and commercialization pipelines even when trade measures create episodic cost volatility.

Multidimensional segmentation analysis clarifying how application, end use, material type, and surface functionalization dictate development and commercialization priorities

A thorough segmentation lens reveals where technical and commercial priorities concentrate and how development pathways diverge across use cases and material attributes. Based on Application, market is studied across Diagnostics, Drug Delivery, Imaging, and Photothermal Therapy, with Diagnostics further examined across Biosensing and Cancer Diagnostics; this segmentation highlights distinct validation requirements, where biosensing applications emphasize surface chemistry stability and signal-to-noise optimization while cancer diagnostics demand rigorous specificity and clinical validation pathways.

Based on End Use Industry, market is studied across Cosmetics, Healthcare, and Research Organizations, and this distinction clarifies commercialization strategies because cosmetic formulations prioritize safe long-term exposure profiles and aesthetic compatibility, healthcare applications require clinical-grade manufacturing and regulatory dossiers, and research organizations often prioritize material versatility and analytical traceability. Based on Material Type, market is studied across Coated and Uncoated, with the Coated category further subdivided into Polyethylene Glycol Coated, Polymer Coated, and Silica Coated, and the Polyethylene Glycol Coated option further detailed into Methoxy Polyethylene Glycol and Thiol Polyethylene Glycol; these material-type differentiations drive decisions about colloidal stability, circulation times in vivo, and functional handle availability for downstream conjugation.

Based on Surface Functionalization, market is studied across Functionalized and Nonfunctionalized, with the Functionalized subset further defined by Antibody Functionalization and DNA Functionalization; this axis is particularly important because the choice of functionalization method dictates target specificity, batch release criteria, and the complexity of immunogenicity assessment. Taken together, these segmentation frameworks provide a multilayered map that helps developers align technical investments to the regulatory and commercial exigencies of each pathway.

Strategic regional analysis showing how regulatory regimes, manufacturing capabilities, and translational ecosystems influence adoption in the Americas, EMEA, and Asia-Pacific

Regional dynamics shape access to talent, capital, regulatory frameworks, and manufacturing infrastructure, and appreciating these differences is essential for realistic go-to-market strategies. In the Americas, there is a strong concentration of translational research centers, clinical trial infrastructure, and contract development organizations that facilitate clinical pipelines; this environment supports rapid iteration between bench discoveries and clinical validation, although it also imposes stringent regulatory and quality expectations that developers must meet.

In Europe, Middle East & Africa, regulatory landscapes vary significantly, with certain jurisdictions offering harmonized pathways that favor cross-border clinical validation, while others require careful localization of dossiers and manufacturing controls. This region also presents a mature cosmetics market and advanced imaging research communities that can be attractive early adopters for non-therapeutic applications. In Asia-Pacific, rapid manufacturing scale-up capability, a growing base of specialized contract manufacturers, and strong government-supported innovation initiatives create favorable conditions for scaling production and pursuing cost-efficient supply chains; however, developers must navigate diverse regulatory regimes and intellectual property protection frameworks.

These regional differences inform pragmatic choices about where to prioritize pilot production, where to locate analytical laboratories, and how to structure partnerships. A regionally adaptive approach that aligns regulatory strategy, manufacturing capabilities, and commercialization timelines with local strengths reduces execution risk and enhances the probability of successful adoption in each jurisdiction.

Competitive landscape assessment identifying how synthesis scale-up capabilities, proprietary coatings, and strategic partnerships create commercial advantage in this specialized materials sector

The competitive environment for oil-soluble gold nanorods is defined by a mix of specialized materials developers, established nanomaterials suppliers, and contract organizations that bridge R&D to production. Leaders in this space are distinguishing themselves through deep expertise in synthesis scale-up, proprietary coating chemistries that enhance dispersion in nonpolar matrices, and validated surface functionalization processes that enable targeted diagnostic and therapeutic uses. Partnerships and licensing arrangements are common because they allow academic innovators to access commercial-grade manufacturing and regulatory expertise while enabling companies to expand their application portfolios without internalizing all R&D risk.

Investment in analytical platforms and quality systems is another axis of differentiation. Firms that can demonstrate robust characterization of particle size distribution, coating consistency, and functionalization yield are better positioned to support regulated applications. Moreover, strategic collaborations with contract development and manufacturing organizations reduce time-to-clinic for therapeutic applications by combining materials expertise with established GMP processes. In parallel, a subset of companies is focusing on adjacent offerings such as formulation services, assay integration, and platform licensing, creating multiple pathways to monetize core intellectual property.

For potential partners and acquirers, the key indicators of strong capability include a proven route to scale, clear quality control protocols, and an ecosystem of validation partners across preclinical and clinical domains. These strengths lower integration risk and increase the potential for successful downstream commercialization.

Practical, prioritized recommendations for executives to stabilize supply chains, enhance analytical rigor, and accelerate translation of oil-soluble gold nanorod technologies

Industry leaders should prioritize actionable steps that balance near-term risk mitigation with investments that unlock long-term commercial value. First, strengthen supplier diversity for key precursors and coating materials to reduce vulnerability to tariff-driven cost swings and supply disruptions. Establish formal qualification protocols for alternate vendors and maintain a prioritized list of vetted suppliers to minimize delays in development programs.

Second, invest in analytical robustness and documentation. Standardize high-resolution characterization methods and implement traceable quality-control procedures across batches to meet regulatory expectations and to build confidence with clinical and industrial partners. Third, pursue modular manufacturing approaches that allow capacity to be scaled regionally and to be reallocated as policy or demand conditions change; this flexibility is critical for managing trade-related uncertainties and for aligning production with local regulatory requirements.

Fourth, accelerate translational partnerships by co-designing validation studies with end users. Collaborative validation with hospitals, diagnostic labs, or cosmetic formulators shortens feedback loops and clarifies performance requirements. Finally, protect and operationalize intellectual property by aligning patent strategies with commercialization roadmaps and by negotiating licensing terms that support joint development while preserving long-term value. Collectively, these measures create resilient operations and clearer pathways to market.

Transparent mixed-methods research methodology combining expert interviews, technical validation, and triangulated evidence to produce actionable insights on oil-soluble gold nanorods

The research approach supporting these insights combined a systematic literature synthesis, targeted expert interviews, and cross-validation of technical and regulatory signals from public documents and company disclosures. Primary qualitative inputs included interviews with materials scientists, formulation chemists, regulatory consultants, and representatives from contract development organizations, each selected for direct experience with plasmonic nanomaterials or translational development processes.

Analytical methods emphasized triangulation: technical assertions were validated through multiple independent sources, and claims about regulatory trends were corroborated with publicly available guidance documents and precedent submissions where accessible. The methodology also integrated a comparative review of coating and functionalization techniques to identify practical trade-offs between stability in oil-based matrices and the capacity for biomolecular conjugation. Throughout, the emphasis was on reproducible and transparent practices that other researchers and decision-makers can apply when assessing technology readiness and commercial viability.

Limitations are acknowledged: proprietary data from private firms and confidential development programs are by nature not fully visible in the public domain, so conclusions weigh public and expert-validated information more heavily. Nevertheless, this mixed-methods approach yields actionable, evidence-based perspectives that support strategic decision-making for developers, investors, and end users.

A concise synthesis of technical, regulatory, and strategic considerations that defines pragmatic pathways to commercialize oil-soluble gold nanorod innovations

Oil-soluble gold nanorods occupy a compelling niche where advanced material properties intersect with diverse application opportunities, but realizing that potential depends on disciplined attention to reproducibility, regulatory alignment, and strategic supply chain design. Technological advancements in synthesis precision, coating chemistries, and functionalization expand the range of feasible applications, while evolving regulatory expectations and trade policies create both constraints and incentives for how developers structure partnerships and manufacturing footprints.

To move from promise to impact, organizations must integrate rigorous analytical processes, flexible manufacturing strategies, and collaborative validation with end users. Prioritizing supplier diversification, investing in robust characterization platforms, and aligning patent and licensing strategies with commercialization roadmaps are practical steps that reduce execution risk. Regional dynamics should inform where to build capacity and how to sequence market entry, with a focus on harmonizing evidence packages to meet the most demanding regulatory standards likely to be encountered.

In sum, the pathway to commercial success for oil-soluble gold nanorods is navigable for organizations that combine technical excellence with strategic operational planning. Those that do will be well positioned to translate materials innovation into differentiated diagnostic, imaging, and therapeutic solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oil-soluble Gold Nanorods Market, by Material Type

  • 8.1. Coated
    • 8.1.1. Polyethylene Glycol Coated
    • 8.1.2. Polymer Coated
    • 8.1.3. Silica Coated
  • 8.2. Uncoated

9. Oil-soluble Gold Nanorods Market, by Surface Functionalization

  • 9.1. Functionalized
    • 9.1.1. Antibody Functionalization
    • 9.1.2. DNA Functionalization
  • 9.2. Nonfunctionalized

10. Oil-soluble Gold Nanorods Market, by Application

  • 10.1. Diagnostics
    • 10.1.1. Biosensing
    • 10.1.2. Cancer Diagnostics
  • 10.2. Drug Delivery
  • 10.3. Imaging
  • 10.4. Photothermal Therapy

11. Oil-soluble Gold Nanorods Market, by End Use Industry

  • 11.1. Cosmetics
  • 11.2. Healthcare
  • 11.3. Research Organizations

12. Oil-soluble Gold Nanorods Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Oil-soluble Gold Nanorods Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Oil-soluble Gold Nanorods Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Oil-soluble Gold Nanorods Market

16. China Oil-soluble Gold Nanorods Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. American Elements
  • 17.6. BBI Solutions by Novo Holdings A/S
  • 17.7. CD Bioparticles
  • 17.8. Cytodiagnostics Inc.
  • 17.9. Emfutur Technologies
  • 17.10. Innova Biosciences
  • 17.11. Meliorum Technologies, Inc.
  • 17.12. nanoComposix by Fortis Life Sciences
  • 17.13. Nanocs, Inc.
  • 17.14. Nanopartz Inc.
  • 17.15. Nanoprobes, Inc.
  • 17.16. Plasmachem GmbH
  • 17.17. RuixiBiotechCo.Ltd
  • 17.18. Sigma-Aldrich Corporation
  • 17.19. TANAKA Holdings Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYETHYLENE GLYCOL COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYETHYLENE GLYCOL COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYETHYLENE GLYCOL COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SILICA COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SILICA COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SILICA COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY UNCOATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY FUNCTIONALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY FUNCTIONALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY FUNCTIONALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DNA FUNCTIONALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DNA FUNCTIONALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DNA FUNCTIONALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY NONFUNCTIONALIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY NONFUNCTIONALIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY NONFUNCTIONALIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOSENSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOSENSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 140. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 142. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 164. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 166. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 169. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 172. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 174. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY COATED, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY FUNCTIONALIZED, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA OIL-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)